Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02348385 · ClinicalTrials.gov registry record
Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 49
- Enrollment target
NCT02348385 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 49 participants.
The verdict
NCT02348385 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
The goal is to examine sex differences in amphetamine-induced dopamine release in tobacco smokers and nonsmokers.
Interventions
- DRUG Amphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2012-12 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02348385
The ClinicalTrials.gov registry entry for NCT02348385 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amphetamine is the first listed.
NCT02348385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02348385 about?
NCT02348385 is a clinical study titled "Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers". The goal is to examine sex differences in amphetamine-induced dopamine release in tobacco smokers and nonsmokers.
What is the current status of trial NCT02348385?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2012-12. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02348385?
The interventions under investigation include: Amphetamine (DRUG).
Who is sponsoring clinical trial NCT02348385?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.